Independent expert analysis of the pipeline in 5 disease areas
Leading dermatologists discuss the innovations shaping 5 chronic skin diseases—psoriasis, atopic dermatitis, alopecia areata, vitiligo, and hidradenitis suppurativa—and share the challenges and opportunities for biopharmaceutical companies developing innovative treatments.
At Fishawack Health (FH), we are committed to investing in the field of dermatology. In November 2022, we welcomed FIDE, an independent network of expert partners in dermatology, to inform industry specialists as to the potential impact of the latest data and how it may affect their strategic decision-making. FIDE joins other Expert Partnerships at FH including IHEP, which specializes in diseases of the liver and i-ONE, which specializes in oncology and hematology. Each Expert Partnership offers unparalleled access to the latest insights from the world’s leading key opinion leaders.
FIDE’s services range from detailed, unbiased conference analysis programs to consulting and training initiatives that bridge the gap between industry’s understanding of the field and real-world clinician and patient perspectives.
We sat down with members of the FIDE Steering Committee to explore the latest key insights and trends in 5 inflammatory skin diseases—psoriasis, atopic dermatitis, alopecia areata, vitiligo, and hidradenitis suppurativa. They examined the complexities of the space and outlined the challenges that new and innovative treatments and technologies can help address, from meeting unmet needs to improving in the provision of high standards of clinical care.
